Other disclosuresNSE · MOREPENLAB
Morepen Laboratories Limited
Press Release
01 / The disclosure
What the company shared
Morepen Laboratories Limited has informed the Exchange regarding a press release dated October 27, 2026, titled "Morepen hits record Q2 revenue of Rs. 755 Cr; EBITDA surges 273% to Rs. 132 Cr; CDMO momentum drives Morepen into a new earnings scale; H1 EBITDA reaches Rs. 220 Cr".
Exchange-provided summary Company profile
A question for your research
Read the underlying filing for the complete disclosure and any conditions not included in the exchange summary.
The evidence
Read the source excerpts
PDF text is unavailable. Read the original filing for the full disclosure.
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 106830033
- First collected
- 27 Oct 2026, 13:51 IST
- PDF extraction
- metadata_only
You’ve reached the end of this disclosure.